In last trading session, Mustang Bio Inc (NASDAQ:MBIO) saw 21.37 million shares changing hands with its beta currently measuring 1.76. Company’s recent per share price level of $0.22 trading at $0.0 or 1.09% at ring of the bell on the day assigns it a market valuation of $11.03M. That closing price of MBIO’s stock is at a discount of -595.45% from its 52-week high price of $1.53 and is indicating a premium of 40.91% from its 52-week low price of $0.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 39.8 million shares which gives us an average trading volume of 7.79 million if we extend that period to 3-months.
For Mustang Bio Inc (MBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Mustang Bio Inc (NASDAQ:MBIO) trade information
Upright in the green during last session for gaining 1.09%, in the last five days MBIO remained trading in the green while hitting it’s week-highest on Thursday, 01/02/25 when the stock touched $0.22 price level, adding 49.87% to its value on the day. Mustang Bio Inc’s shares saw a change of 25.65% in year-to-date performance and have moved 25.65% in past 5-day. Mustang Bio Inc (NASDAQ:MBIO) showed a performance of 15.59% in past 30-days. Number of shares sold short was 0.37 million shares which calculate 0.61 days to cover the short interests.
Mustang Bio Inc (MBIO) estimates and forecasts
Statistics highlight that Mustang Bio Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -49.72% of value to its shares in past 6 months, showing an annual growth rate of 86.50% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.87% during past 5 years.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
Insiders are in possession of 15.68% of company’s total shares while institution are holding 5.72 percent of that, with stock having share float percentage of 6.79%. Investors also watch the number of corporate investors in a company very closely, which is 5.72% institutions for Mustang Bio Inc that are currently holding shares of the company.
